You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PROMETHAZINE VC PLAIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Promethazine Vc Plain, and what generic alternatives are available?

Promethazine Vc Plain is a drug marketed by Cenci and Xttrium Labs Inc and is included in two NDAs.

The generic ingredient in PROMETHAZINE VC PLAIN is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROMETHAZINE VC PLAIN?
  • What are the global sales for PROMETHAZINE VC PLAIN?
  • What is Average Wholesale Price for PROMETHAZINE VC PLAIN?
Drug patent expirations by year for PROMETHAZINE VC PLAIN
Drug Prices for PROMETHAZINE VC PLAIN

See drug prices for PROMETHAZINE VC PLAIN

Recent Clinical Trials for PROMETHAZINE VC PLAIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Trauma CenterN/A
Oman Medical Speciality BoardPhase 3
Tanta UniversityN/A

See all PROMETHAZINE VC PLAIN clinical trials

US Patents and Regulatory Information for PROMETHAZINE VC PLAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci PROMETHAZINE VC PLAIN phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088815-001 Nov 22, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xttrium Labs Inc PROMETHAZINE VC PLAIN phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088897-001 Jan 4, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.